Breast Cancer,HER2- BioItaLEE Trial: The Role of ctDNA and TKa in HR+, HER2- Advanced Breast Cancer Patients May 19, 2023
Breast Cancer,HER2- QoL in 1L HR+/HER2- ABC Compared: Ribociclib + AI vs. Abemaciclib + AI (MAIC Analysis) May 19, 2023
Breast Cancer,HER2- Palbociclib and Endocrine Therapy for Metastatic Breast Cancer Patients May 19, 2023
Breast Cancer,TNBC (Triple Negative Breast Cancer) Improved OS in Postmenopausal HR+/HER2- ABC Patients With RIB and FUL Apr 28, 2023
Breast Cancer,TNBC (Triple Negative Breast Cancer) Breakthrough in Triple Negative Breast Cancer Treatment: GeparNuevo Study Apr 28, 2023
Breast Cancer,TNBC (Triple Negative Breast Cancer) Talazoparib Monotherapy for Homologous Recombination Gene Mutations Apr 28, 2023
Breast Cancer,HER2+ Phase 3 PRECIOUS Study: Pertuzumab Retreatment Benefits for HER2+ Cancer Patients Mar 28, 2023
Breast Cancer,HER2- Comparison of PAL + FUL vs. CAPE in the GEICAM/2013-02 (PEARL) Phase 3 Trial Mar 28, 2023
